NEW YORK and CAESAREA, Israel, April
1, 2019 /PRNewswire/ -- Global #digitaltherapeutics
innovator DarioHealth Corp. (Nasdaq: DRIO) today announced an
agreement with Cupertino-based Auer Integrative Health's Functional
Medicine and Chiropractic, a Silicon Valley medical clinic.
Auer Integrative, a leader in the U.S., will use the
DarioEngage™ healthcare provider platform from DarioHealth to
remotely monitor, engage and manage patients with diabetes and
pre-diabetes. The platform allows the clinic to support their
all-inclusive patient diabetes management program, in which
patients receive health and wellness coaching virtually and via
phone. Auer Integrative will adopt Dario's Per Engaged Member, Per
Month (PEMPM) business model.
DarioHealth sees clinics as ideal partners to scale up its
growth and deliver tangible medical outcomes while providing users
with the outstanding experience of diabetes support and lifestyle
coaching from their healthcare provider.
"The direct, real-time access to patient blood glucose levels
and everyday data related to nutrition and exercise captured by
Dario on the patient's smartphone transforms the ability of our
patients to effect better health. Making this information available
to our healthcare professionals makes them much more efficient in
addressing the most important topics with their patients,"
commented Daniel Auer DC, medical director of Auer Integrative.
"This is very valuable to us because we can now engage with
patients, more effectively, more often, through direct virtual
interactions."
"Chronic illness is the biggest driver of healthcare costs on a
national scale as well as on a household scale," commented
Erez Raphael, DarioHealth CEO. "By
providing tools that strongly engage the users, enable intuitive
lifestyle changes and reduce or delay the impact of diabetes
complications, providers are able to deliver better clinical
outcomes and meaningfully reduce the costs of chronic illness for
the payer and for the individual. Clinical evidence, based on
Dario's data, demonstrates that our superior engagement rates lead
to significant and sustainable A1c reduction and increase of
in-range glucose measurements."
For those patients opting out of remote monitoring, the clinic
will stock Dario starter kits and products onsite in its Cupertino
clinic.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading global
Digital Therapeutics (DTx) company revolutionizing the way people
manage their health across the chronic condition spectrum. By
delivering evidence-based interventions that are driven by data,
high-quality software and coaching, we developed a novel approach
that empowers individuals to adjust their lifestyle in a
personalized way. Our Cross Functional Team operates at the
intersection of life sciences, behavioral science and software
technology to deliver highly engaging therapeutic interventions.
Already one of the highest rated diabetes solutions, its
user-centric approach is loved by tens of thousands of consumers
around the globe. DarioHealth is rapidly moving into new chronic
conditions and geographic markets.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and
partners of DarioHealth Corp. (the "Company") related thereto
contain or may contain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Statements that are not statements of historical fact may be deemed
to be forward-looking statements. Without limiting the generality
of the foregoing, words such as "plan," "project," "potential,"
"seek," "may," "will," "expect," "believe," "anticipate," "intend,"
"could," "estimate," or "continue" are intended to identify
forward-looking statements. For example, when the Company states
that it sees clinics as ideal partners to scale up the growth of
its user base and that tools such as the DarioEngage results in
providers being able to deliver better clinical outcomes and
meaningfully reduce the costs of chronic illness for the payer and
the individual, it is using forward-looking statements. Readers are
cautioned that certain important factors may affect the Company's
actual results and could cause such results to differ materially
from any forward-looking statements that may be made in this news
release. Factors that may affect the Company's results include, but
are not limited to, regulatory approvals, product demand, market
acceptance, impact of competitive products and prices, product
development, commercialization or technological difficulties, the
success or failure of negotiations and trade, legal, social and
economic risks, and the risks associated with the adequacy of
existing cash resources. Additional factors that could cause or
contribute to differences between the Company's actual results and
forward-looking statements include, but are not limited to, those
risks discussed in the Company's filings with the U.S. Securities
and Exchange Commission. Readers are cautioned that actual results
(including, without limitation, the timing for and results of the
Company's commercial and regulatory plans for Dario) may differ
significantly from those set forth in the forward-looking
statements. The Company undertakes no obligation to publicly update
any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
applicable law.
DarioHealth Corporate Contact:
Joao Mendes-Roter
VP Marketing
joao@mydario.com
+1-347-767-4220
View original content to download
multimedia:http://www.prnewswire.com/news-releases/dariohealth-signs-leading-functional-medicine-clinic-to-darioengage-remote-digital-diabetes-platform-300821675.html
SOURCE DarioHealth Corp.